These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2721636)
1. VLDL substrate properties and efficiency of their metabolic transformation by LPL. Dergunov AD; Shuvaev VV; Perova NV Experientia; 1989 May; 45(5):461-3. PubMed ID: 2721636 [TBL] [Abstract][Full Text] [Related]
2. Lipoprotein lipase-catalyzed hydrolysis of phosphatidylcholine of guinea pig very low density lipoproteins and discoidal complexes of phospholipid and apolipoprotein: effect of apolipoprotein C-II on the catalytic mechanism. Shirai K; Fitzharris TJ; Shinomiya M; Muntz HG; Harmony JA; Jackson RL; Quinn DM J Lipid Res; 1983 Jun; 24(6):721-30. PubMed ID: 6688442 [TBL] [Abstract][Full Text] [Related]
3. Very low density lipoprotein. Removal of Apolipoproteins C-II and C-III-1 during lipolysis in vitro. Eisenberg S; Patsch JR; Sparrow JT; Gotto AM; Olivecrona T J Biol Chem; 1979 Dec; 254(24):12603-8. PubMed ID: 227902 [TBL] [Abstract][Full Text] [Related]
4. Reduced lipolysis of large apo E-poor very-low-density lipoprotein subfractions from type IV hypertriglyceridemic subjects in vitro and in vivo. Evans AJ; Wolfe BM; Strong WL; Huff MW Metabolism; 1993 Jan; 42(1):105-15. PubMed ID: 8446037 [TBL] [Abstract][Full Text] [Related]
5. Topo-dynamic characteristics of human plasma VLDL apolipoproteins and efficiency of triacylglycerol hydrolysis by lipoprotein lipase. Dergunov AD; Shuvaev VV; Perova NV Biochim Biophys Acta; 1989 Sep; 1005(1):79-86. PubMed ID: 2775763 [TBL] [Abstract][Full Text] [Related]
6. In vitro catabolism of human very low density lipoproteins: fate of apoproteins B and C. Catapano AL; Capurso A; Kinnunen PK Artery; 1981; 9(2):87-95. PubMed ID: 7295047 [TBL] [Abstract][Full Text] [Related]
7. Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions. Yamamoto M; Morita SY; Kumon M; Kawabe M; Nishitsuji K; Saito H; Vertut-Doï A; Nakano M; Handa T Biochim Biophys Acta; 2003 Jun; 1632(1-3):31-9. PubMed ID: 12782148 [TBL] [Abstract][Full Text] [Related]
8. Effect of the apolipoprotein C-II/C-III1 ratio on the capacity of purified milk lipoprotein lipase to hydrolyse triglycerides in monolayer vesicles. Lambert DA; Catapano AL; Smith LC; Sparrow JT; Gotto AM Atherosclerosis; 1996 Dec; 127(2):205-12. PubMed ID: 9125310 [TBL] [Abstract][Full Text] [Related]
9. In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia. van Barlingen HH; Kock LA; de Man FH; Erkelens DW; de Bruin TW Atherosclerosis; 1996 Mar; 121(1):75-84. PubMed ID: 8678926 [TBL] [Abstract][Full Text] [Related]
10. Lipolysis-induced degradation of apolipoproteins B and E of human very low density lipoproteins. Chung BH; Im JH; Bowdon HR J Biol Chem; 1986 Feb; 261(6):2960-7. PubMed ID: 3949755 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375 [TBL] [Abstract][Full Text] [Related]
12. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins. Tornoci L; Scheraldi CA; Li X; Ide H; Goldberg IJ; Le NA J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727 [TBL] [Abstract][Full Text] [Related]
13. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III. Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516 [TBL] [Abstract][Full Text] [Related]
14. Activation of the phospholipase A1 activity of lipoprotein lipase by apoprotein C-II. Stocks J; Galton DJ Lipids; 1980 Mar; 15(3):186-90. PubMed ID: 7374370 [TBL] [Abstract][Full Text] [Related]
15. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product. Alaupovic P; Wang CS; McConathy WJ; Weiser D; Downs D Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947 [TBL] [Abstract][Full Text] [Related]
16. Studies of a variant very-low-density lipoprotein with an acquired deficiency of apolipoprotein C-II. Reckless JP; Stocks J; Holdsworth G; Galton DJ; Suggett AJ; Walton KW Clin Sci (Lond); 1982 Jan; 62(1):93-100. PubMed ID: 7056035 [TBL] [Abstract][Full Text] [Related]
17. Kinetics of in vitro lipolysis of human very low-density lipoprotein by lipoprotein lipase. Schreier L; Berg G; Zago V; Gonzalez AI; Wikinski R Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):13-8. PubMed ID: 12125224 [TBL] [Abstract][Full Text] [Related]
18. The comparative kinetics of soluble and heparin-Sepharose-immobilized bovine lipoprotein lipase. Posner I; Wang CS; McConathy WJ Arch Biochem Biophys; 1983 Oct; 226(1):306-16. PubMed ID: 6639055 [TBL] [Abstract][Full Text] [Related]
19. Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL. Murdoch SJ; Breckenridge WC Biochim Biophys Acta; 1996 Oct; 1303(3):222-32. PubMed ID: 8908157 [TBL] [Abstract][Full Text] [Related]
20. Reciprocal effect of apolipoprotein C-II on the lipoprotein lipase-catalyzed hydrolysis of p-nitrophenyl butyrate and trioleoylglycerol. Shirai K; Jackson RL; Quinn DM J Biol Chem; 1982 Sep; 257(17):10200-3. PubMed ID: 7107600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]